Us Bancorp \De\ Pulse Biosciences, Inc. Transaction History
Us Bancorp \De\
- $75.6 Billion
- Q4 2024
A detailed history of Us Bancorp \De\ transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 2 shares of PLSE stock, worth $38. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2
Previous 105
98.1%
Holding current value
$38
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLSE
# of Institutions
78Shares Held
5.75MCall Options Held
94.9KPut Options Held
52K-
Black Rock Inc. New York, NY1.15MShares$22.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$22.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC788KShares$15.2 Million0.0% of portfolio
-
State Street Corp Boston, MA474KShares$9.12 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA461KShares$8.87 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $714M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...